AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Targeting Pre-Transplant MRT for Improved AML Patient Outcomes
This chapter discusses the potential of targeting pre transplant minimal residual disease (MRT) in AML patients to reduce relapse and improve transplant outcomes. They emphasize the lack of clinical trials in this area and the importance of standardizing MRT assays for the benefit of patients and the development of new therapies.